Biopharmaceutical CMO & CRO Market - Global Forecast 2026-2032

The biopharmaceutical CMO & CRO market is experiencing rapid evolution, marked by shifting partnerships, technological advancements, and supply chain realignment—factors that are significantly influencing strategic priorities for senior leaders across the sector.

Market Snapshot

The Biopharmaceutical CMO & CRO Market grew from USD 113.74 billion in 2025 to USD 135.25 billion in 2026, demonstrating robust expansion. Expected to maintain strong momentum at a CAGR of 19.09%, the market is forecast to reach USD 386.58 billion by 2032. This trajectory reflects escalating innovation across advanced modalities, intensifying demand for accelerated clinical scale-up, and diversified sponsor expectations shaping contract services worldwide.

Scope & Segmentation

Service Types: Analytical, Cell Culture, Clinical Development (Phases I-III), Fill-Finish, Formulation, Preclinical Development, Process Development
Product Categories: Large Molecule (Biologics, Biosimilars; further segmented into Monoclonal Antibodies, Recombinant Proteins, Vaccines), Small Molecule (Generics, New Chemical Entities)
Application Areas: Cell Therapies (CAR T, Stem Cell), Gene Therapies (Viral Vector, Non Viral), Monoclonal Antibodies (Bispecific, Conjugated, Naked), Recombinant Proteins (Enzymes, Growth Factors, Hormones), Vaccines (mRNA, Inactivated, Live Attenuated, Subunit)
End Users: Biotechnology Companies (Large, Small), CROs (Full Service, Niche Service), Pharmaceutical Companies (Tier I–III), Research Institutions (Academia, Government)
Regions Covered: Americas, Europe Middle East & Africa, Asia-Pacific
Technologies: Platform technologies, advanced analytics, modular facilities, digital solutions (real-time analytics, digital batch records, cloud-native data architectures)

Key Takeaways

Strategic partnerships and vertical integration are increasingly vital, helping companies secure critical inputs and manage regulatory complexity.
Platform depth, digital capability, and supply chain resilience are distinguishing leaders from the competition in biologics, cell, and gene therapy segments.
Flexible commercial models, including milestone-based contracts and capacity reservation agreements, are favored as sponsors seek to share both risks and rewards.
Providers investing in modular, multiproduct facilities and robust data governance are more likely to win long-term client relationships.
Segmentation along service, product, application, and end-user dimensions reveals clear opportunities for tailored investment and market differentiation.
Regional dynamics—especially around regulatory timelines and supply chain strategies—require nuanced approaches when planning capacity, ensuring compliance, and optimizing go-to-market efforts.

Tariff Impact

The 2025 introduction of new tariffs has altered procurement strategies, favoring multi-sourcing and nearshoring of critical manufacturing steps to offset increased input costs and mitigate supply vulnerabilities. This shift extends procurement timelines and has prompted the adoption of more complex cost-recovery and hedging mechanisms in contracts. Organizations now emphasize process intensification to achieve greater yield while embedding contractual safeguards against future trade-policy changes. Regulatory interactions are more dynamic, with increased use of comparability protocols and contingency filings to support uninterrupted product delivery.

Methodology & Data Sources

This report integrates structured primary interviews with executives, technical leads, and procurement specialists, validated with targeted secondary review of regulatory documents, industry filings, and technical literature. Thematic synthesis and scenario validation ensure a defensible basis for insights and recommendations. Peer review and external validation reinforce the practical relevance for current industry challenges.

Biopharmaceutical CMO & CRO Market: Why This Report Matters

Enables senior decision-makers to benchmark service capabilities, segment growth, and regional strengths in a highly dynamic environment.
Provides actionable guidance to realign investments, fortify supply chains, and implement digital and commercial innovations for risk mitigation.
Supports procurement, R&D, and commercial leaders with segmentation maps essential for technology transfer, partnership decisions, and capital allocation.

Conclusion

Achieving long-term competitive positioning in the biopharmaceutical CMO & CRO market requires integrated technical capabilities and resilient supply chain structures. Senior leaders who focus on digital enablement, regional alignment, and tailored customer engagement will optimize outcomes and accelerate development cycles.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Biopharmaceutical CMO & CRO Market, by Product Type

8.1. Large Molecule
8.1.1. Biologics
8.1.1.1. Monoclonal Antibodies
8.1.1.2. Recombinant Proteins
8.1.1.3. Vaccines
8.1.2. Biosimilars
8.2. Small Molecule
8.2.1. Generics
8.2.2. New Chemical Entities

9. Biopharmaceutical CMO & CRO Market, by Service Type

9.1. Analytical
9.2. Cell Culture
9.3. Clinical Development
9.3.1. Phase I
9.3.2. Phase II
9.3.3. Phase III
9.4. Fill-Finish
9.5. Formulation
9.6. Preclinical Development
9.7. Process Development

10. Biopharmaceutical CMO & CRO Market, by Therapeutic Area

10.1. Oncology
10.2. Infectious Diseases
10.3. Cardiovascular
10.4. Central Nervous System
10.5. Immunology And Inflammation
10.6. Respiratory
10.7. Metabolic And Endocrine
10.8. Rare Diseases

11. Biopharmaceutical CMO & CRO Market, by Application

11.1. Cell Therapies
11.1.1. CAR T
11.1.2. Stem Cell
11.2. Gene Therapies
11.2.1. Non Viral
11.2.2. Viral Vector
11.3. Monoclonal Antibodies
11.3.1. Bispecific
11.3.2. Conjugated
11.3.3. Naked
11.4. Recombinant Proteins
11.4.1. Enzymes
11.4.2. Growth Factors
11.4.3. Hormones
11.5. Vaccines
11.5.1. Inactivated
11.5.2. Live Attenuated
11.5.3. mRNA
11.5.4. Subunit

12. Biopharmaceutical CMO & CRO Market, by End User

12.1. Biotechnology Companies
12.1.1. Large Biotech
12.1.2. Small Biotech
12.2. CROs
12.2.1. Full Service
12.2.2. Niche Service
12.3. Pharmaceutical Companies
12.3.1. Tier I
12.3.2. Tier II
12.3.3. Tier III
12.4. Research Institutions
12.4.1. Academia
12.4.2. Government

13. Biopharmaceutical CMO & CRO Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Biopharmaceutical CMO & CRO Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Biopharmaceutical CMO & CRO Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Biopharmaceutical CMO & CRO Market
17. China Biopharmaceutical CMO & CRO Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AbbVie Inc.
18.6. AbbVie, Inc.
18.7. arexel International Corporation
18.8. Baxter International Inc.
18.9. Boehringer Ingelheim Biopharmaceuticals GmbH
18.10. Boehringer Ingelheim GmbH
18.11. Catalent, Inc.
18.12. Charles River Laboratories International, Inc.
18.13. Eurofins Scientific Limited
18.14. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
18.15. ICON Plc
18.16. KBI Biopharma, Inc.
18.17. KEMWELL BIOPHARMA PRIVATE LIMITED
18.18. Laboratory Corporation of America Holdings
18.19. Lonza Group AG
18.20. NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JSC
18.21. Patheon Inc.
18.22. Rentschler Biopharma SE
18.23. Sterling Pharma Solutions

List of Figures

FIGURE 1. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE MOLECULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE MOLECULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE MOLECULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE MOLECULE, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOSIMILARS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOSIMILARS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOSIMILARS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL MOLECULE, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL MOLECULE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL MOLECULE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL MOLECULE, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENERICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENERICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENERICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY NEW CHEMICAL ENTITIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY NEW CHEMICAL ENTITIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY NEW CHEMICAL ENTITIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY ANALYTICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY ANALYTICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY ANALYTICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL CULTURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL CULTURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CLINICAL DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CLINICAL DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CLINICAL DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CLINICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHASE I, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHASE I, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHASE I, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHASE II, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHASE II, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHASE II, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHASE III, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHASE III, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHASE III, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY FILL-FINISH, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY FILL-FINISH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY FILL-FINISH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY FORMULATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY FORMULATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY FORMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRECLINICAL DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PROCESS DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PROCESS DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY IMMUNOLOGY AND INFLAMMATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY IMMUNOLOGY AND INFLAMMATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY IMMUNOLOGY AND INFLAMMATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RESPIRATORY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RESPIRATORY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY METABOLIC AND ENDOCRINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY METABOLIC AND ENDOCRINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY METABOLIC AND ENDOCRINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RARE DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RARE DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL THERAPIES, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CAR T, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CAR T, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CAR T, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY STEM CELL, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY STEM CELL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY STEM CELL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENE THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENE THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENE THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENE THERAPIES, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY NON VIRAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY NON VIRAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY NON VIRAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VIRAL VECTOR, BY REGION, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VIRAL VECTOR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VIRAL VECTOR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BISPECIFIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BISPECIFIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BISPECIFIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CONJUGATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CONJUGATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CONJUGATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY NAKED, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY NAKED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY NAKED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY ENZYMES, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GROWTH FACTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GROWTH FACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY HORMONES, BY REGION, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY HORMONES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY HORMONES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY INACTIVATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY INACTIVATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LIVE ATTENUATED, BY REGION, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LIVE ATTENUATED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LIVE ATTENUATED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MRNA, BY REGION, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MRNA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MRNA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SUBUNIT, BY REGION, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SUBUNIT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SUBUNIT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE BIOTECH, BY REGION, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE BIOTECH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE BIOTECH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL BIOTECH, BY REGION, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL BIOTECH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL BIOTECH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CROS, BY REGION, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CROS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CROS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CROS, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY FULL SERVICE, BY REGION, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY FULL SERVICE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY FULL SERVICE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY NICHE SERVICE, BY REGION, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY NICHE SERVICE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY NICHE SERVICE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY TIER I, BY REGION, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY TIER I, BY GROUP, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY TIER I, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY TIER II, BY REGION, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY TIER II, BY GROUP, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY TIER II, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY TIER III, BY REGION, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY TIER III, BY GROUP, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY TIER III, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RESEARCH INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RESEARCH INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY ACADEMIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY ACADEMIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY ACADEMIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GOVERNMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GOVERNMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GOVERNMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 198. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 199. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 200. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE MOLECULE, 2018-2032 (USD MILLION)
TABLE 201. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 202. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL MOLECULE, 2018-2032 (USD MILLION)
TABLE 203. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 204. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CLINICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 205. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 206. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 207. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL THERAPIES, 2018-2032 (USD MILLION)
TABLE 208. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENE THERAPIES, 2018-2032 (USD MILLION)
TABLE 209. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2032 (USD MILLION)
TABLE 210. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
TABLE 211. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 212. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 213. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 214. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CROS, 2018-2032 (USD MILLION)
TABLE 215. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 216. AMERICAS BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 217. NORTH AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 218. NORTH AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 219. NORTH AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE MOLECULE, 2018-2032 (USD MILLION)
TABLE 220. NORTH AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 221. NORTH AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL MOLECULE, 2018-2032 (USD MILLION)
TABLE 222. NORTH AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 223. NORTH AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CLINICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 224. NORTH AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 225. NORTH AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 226. NORTH AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL THERAPIES, 2018-2032 (USD MILLION)
TABLE 227. NORTH AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENE THERAPIES, 2018-2032 (USD MILLION)
TABLE 228. NORTH AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2032 (USD MILLION)
TABLE 229. NORTH AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
TABLE 230. NORTH AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 231. NORTH AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 232. NORTH AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 233. NORTH AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CROS, 2018-2032 (USD MILLION)
TABLE 234. NORTH AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 235. NORTH AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 236. LATIN AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 237. LATIN AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 238. LATIN AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE MOLECULE, 2018-2032 (USD MILLION)
TABLE 239. LATIN AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 240. LATIN AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL MOLECULE, 2018-2032 (USD MILLION)
TABLE 241. LATIN AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 242. LATIN AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CLINICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 243. LATIN AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 244. LATIN AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 245. LATIN AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL THERAPIES, 2018-2032 (USD MILLION)
TABLE 246. LATIN AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENE THERAPIES, 2018-2032 (USD MILLION)
TABLE 247. LATIN AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2032 (USD MILLION)
TABLE 248. LATIN AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
TABLE 249. LATIN AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 250. LATIN AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 251. LATIN AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 252. LATIN AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CROS, 2018-2032 (USD MILLION)
TABLE 253. LATIN AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 254. LATIN AMERICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE MOLECULE, 2018-2032 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL MOLECULE, 2018-2032 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CLINICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL THERAPIES, 2018-2032 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENE THERAPIES, 2018-2032 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2032 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CROS, 2018-2032 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 274. EUROPE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 275. EUROPE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 276. EUROPE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE MOLECULE, 2018-2032 (USD MILLION)
TABLE 277. EUROPE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 278. EUROPE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL MOLECULE, 2018-2032 (USD MILLION)
TABLE 279. EUROPE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 280. EUROPE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CLINICAL DEVELOPMENT, 2018-2032 (USD MILLION)
TABLE 281. EUROPE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 282. EUROPE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 283. EUROPE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CELL THERAPIES, 2018-2032 (USD MILLION)
TABLE 284. EUROPE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY GENE THERAPIES, 2018-2032 (USD MILLION)
TABLE 285. EUROPE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2032 (USD MILLION)
TABLE 286. EUROPE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2032 (USD MILLION)
TABLE 287. EUROPE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY VACCINES, 2018-2032 (USD MILLION)
TABLE 288. EUROPE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 289. EUROPE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, 2018-2032 (USD MILLION)
TABLE 290. EUROPE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY CROS, 2018-2032 (USD MILLION)
TABLE 291. EUROPE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 292. EUROPE BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY RESEARCH INSTITUTIONS, 2018-2032 (USD MILLION)
TABLE 293. MIDDLE EAST BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 294. MIDDLE EAST BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 295. MIDDLE EAST BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY LARGE MOLECULE, 2018-2032 (USD MILLION)
TABLE 296. MIDDLE EAST BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY BIOLOGICS, 2018-2032 (USD MILLION)
TABLE 297. MIDDLE EAST BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SMALL MOLECULE, 2018-2032 (USD MILLION)
TABLE 298. MIDDLE EAST BIOPHARMACEUTICAL CMO & CRO MARKET SIZE, BY SERVICE TYPE, 20

Companies Mentioned

The key companies profiled in this Biopharmaceutical CMO & CRO market report include:

AbbVie Inc.
AbbVie, Inc.
arexel International Corporation
Baxter International Inc.
Boehringer Ingelheim Biopharmaceuticals GmbH
Boehringer Ingelheim GmbH
Catalent, Inc.
Charles River Laboratories International, Inc.
Eurofins Scientific Limited
FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
ICON Plc
KBI Biopharma, Inc.
KEMWELL BIOPHARMA PRIVATE LIMITED
Laboratory Corporation of America Holdings
Lonza Group AG
NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JSC
Patheon Inc.
Rentschler Biopharma SE
Sterling Pharma Solutions

Table Information

Report Attribute	Details
No. of Pages	189
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 135.25 Billion
Forecasted Market Value ( USD ) by 2032	$ 386.58 Billion
Compound Annual Growth Rate	19.0%
Regions Covered	Global
No. of Companies Mentioned	20

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3513EUR$3,939USD£3,047GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3789EUR$4,249USD£3,286GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5136EUR$5,759USD£4,454GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6215EUR$6,969USD£5,390GBP

Market Snapshot

Scope & Segmentation

Key Takeaways

Tariff Impact

Methodology & Data Sources

Biopharmaceutical CMO & CRO Market: Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Biopharmaceutical CMO and CRO Market Report 2025

Contract Research Organization (CRO) Services Market by Type (Early Phase, Clinical, Lab, Consulting), Therapeutic Area (Cancer (Breast, Lung), Infectious, Neurology, Vaccines), Modality (Small Molecules, Biologics, Biosimilars) - Global Forecast to 2030

In-Vivo CRO Market - Global Strategic Business Report

Cell and Gene Therapy CRO Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Type of Cell Therapy, Type of Genetic Modification, Stage of Development, Therapeutic Area, End-Users and Key Geographical Regions

Central Lab Services/Clinical Trial Lab Services Market by Phase (Phase I, II, III), Service Type (Safety Testing, Immunology), Therapeutic Area (Oncology), Modality (Small Molecules, Vaccine), End User (Pharma & CROs) & Region - Global Forecast to 2030